IP Library Granted Patent US 7,250,504
Granted Patent B2
US 7,250,504 · App. 10/964,313 · Granted Jul 31, 2007

Class II human histone deacetylases, and uses related thereto

Assignee: President and Fellows of Harvard College
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,250,504
App. No.
10/964,313
Granted
Jul 31, 2007
Kind
B2
Abstract

The invention provides histone deacetylase class II nucleic acids and polypeptides, methods and reagents for their use, and related compounds including small molecule libraries containing class II histone deacetylase inhibitors.

Claims (10)

1. An isolated nucleic acid encoding a polypeptide, which polypeptide comprises a polypeptide sequence at least 95% identical to SEQ ID NO: 4 wherein said polypeptide or a fragment thereof has histone deacetylase activity and/or a histone binding activity.

2. The isolated nucleic acid of claim 1 , which polypeptide comprises a polypeptide sequence at least 97% identical to SEQ ID NO: 4 wherein said polypeptide or a fragment thereof has histone deacetylase activity and/or a histone binding activity.

3. The isolated nucleic acid of claim 2 , which polypeptide comprises a polypeptide sequence at least 98% identical to SEQ ID NO: 4 wherein said polypeptide or a fragment thereof has histone deacetylase activity and/or a histone binding activity.

4. The isolated nucleic acid of claim 3 , which polypeptide comprises a polypeptide sequence at least 99% identical to SEQ ID NO: 4 wherein said polypeptide or a fragment thereof has histone deacetylase activity and/or a histone binding activity.

5. The isolated nucleic acid of claim 4 , which polypeptide comprises the polypeptide sequence of SEQ ID NO: 4 or a fragment thereof having histone deacetylase activity and/or a histone binding activity.

6. An isolated nucleic acid encoding a polypeptide having the sequence of SEQ ID NO: 3.

7. The nucleic acid of claim 6 , wherein the polypeptide is a fusion protein.

8. The nucleic acid of claim 6 , further comprising a transcriptional regulatory sequence operably linked to said nucleotide sequence so as to render said nucleic acid suitable for use as an expression vector.

9. An expression vector, capable of replicating in a prokaryotic cell a or eukaryotic cell, comprising the nucleic acid of claim 8 .

10. A isolated host cell transfected with the expression vector of claim 9 .

Assignments (2)
CONFIRMATORY LICENSE Recorded Oct 1, 2012
From: HARVARD UNIVERSITY, PRESIDENT AND FELLOWS OF HARVARD COLLEGE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029061/0434 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2009
From: SCHREIBER FOR HIMSELF AND AS AGENT FOR HOWARD HUGHES MEDICAL INSTITUTE, STUART L.; GROZINGER, CHRISTINA M.; HASSIG, CHRISTIAN A.
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 022134/0009 →
Continuity (3)
Continuation 0980018700 · Mar 5, 2001
Provisional Application 6018680200 · Mar 3, 2000
Related Publication 20050287629A1 · Dec 29, 2005